MSN: COVID-19 vaccine study
UC faculty members involved in upcoming trial at Cincinnati Children's studying a new vaccine
Cincinnati Children's Hospital Medical Center will begin human trials for a COVID-19 vaccine in the upcoming weeks, and the screening process has already begun for people who want to participate.
"We are excited about this vaccine and think it has the possibility to decrease the risk of infection from COVID-19,” says Robert Frenck, MD, who will lead the study. Frenck is a professor of pediatrics at the UC College of Medicine and is medical director for the Division of Infectious Diseases and director of the Vaccine Research Center at Cincinnati Children's.
Watch the full WCPO-TV, Channel 9 story.
Carl Fichtenbaum, MD, professor in the Division of Infectious Diseases at the UC College of Medicine and a UC Health physician, applauded the efforts and expertise of his colleagues.
"It's a very cool study design that allows for flexibility," he says. "Cincinnati Children's is a powerhouse in vaccine development, going back to the days of Albert Sabin and the development of the polio vaccine."
Read the full MSN.com article.
Fichtenbaum also weighed in on other promising vaccine studies, like those coming from Massachusetts-based Moderna, Incorporated and another by researchers at Oxford University.
Watch the full WLWT-TV, Channel 5 story.
Featured photo/Colleen Kelley/UC Creative + Brand
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Stay up on all UC's COVID-19 stories, read more #UCtheGood content, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.